Inclusion Criteria:~* Be at least 50 years of age;~* Have a diagnosis of probable Alzheimer's Disease;~* Have
an MMSE score of > or = 10 and < or = 24;~* Must have a caregiver who is able to attend all study visits;~*
Have received continuous treatment with donepezil for at least 6 months prior to screening, and received a
stable dose of 5 mg/day or 10 mg/day for at least the last 3 of these 6 months.~
